Mary Kay Reveals Two Breakthrough Research Studies In Dermatology

 

Mary Kay Inc. recently revealed the results of two breakthrough research studies at the 2024 Society of Investigative Dermatology. (Photo: Mary Kay Inc.)

KUALA LUMPUR, June 21 (Bernama) -- Mary Kay Inc scientists has revealed the results of two breakthrough research studies at the 2024 Society of Investigative Dermatology (SID) meeting in Dallas, Texas.

The first finding focuses on an antioxidant treatment that can diminish the visible effects of pollution and ageing on human skin; while the second focuses on the applications of computational tools to accurately predict the safety and potential reactions of human skin to various cosmetic ingredients.

“Mary Kay scientists are at the forefront of skin care research, and we are pleased to share our latest findings with the broader scientific community,” said Mary Kay Chief Innovation Officer, Product & Science, Dr Lucy Gildea.

The ongoing partnership with SID underscores Mary Kay’s dedication to advancing skincare science, according to the company in a statement.

By maintaining collaborative efforts, the company remains steadfast in its commitment to making significant breakthroughs in the field of dermatology, ultimately providing consumers with safer and more effective skincare solutions.

Furthermore, Mary Kay is leveraging computational toxicology tools to enhance ingredient safety assessment of cosmetic and personal care ingredients, involving the use of advanced computational methods to predict the safety and potential toxicity of ingredients at an early stage, significantly reducing the need for extensive laboratory testing.

By integrating these advanced tools, Mary Kay underscores its commitment to leveraging cutting-edge technology for product development, ensuring the highest standards of safety and efficacy for its consumers.

Dr Gildea also hosted a compelling panel at SID, titled "Insights into the Effects of Pollution on Skin Health: Recent Discoveries & Emerging Perspectives”, comprising experts from varied fields of dermatology and molecular biology.

The sponsorship and findings presented at the 2024 SID meeting represent the latest efforts by the silver-level sponsor of the event, to reinforce the brand’s long-standing commitment to advancing research and development in skin health and beauty.

With over 1,600 patents for products, technologies, and packaging designs in its global portfolio, Mary Kay continues to lead the way in skincare innovation.

-- BERNAMA